| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A new catheter-integrated drug-delivery system for controlled intravesical mitomycin C release
|
Stærk, Kristian
|
|
|
40 |
9 |
p. 409.e19-409.e26
|
artikel
|
| 2 |
Barriers to sexual recovery in men with prostate, bladder and colorectal cancer
|
Zhu, Alexander
|
|
|
40 |
9 |
p. 395-402
|
artikel
|
| 3 |
Benefit of lymph node dissection in cN+ patients in the treatment of upper tract urothelial carcinoma: Analysis of NCDB registry
|
Piontkowski, Austin J.
|
|
|
40 |
9 |
p. 409.e9-409.e17
|
artikel
|
| 4 |
Characterizing molecular subtypes of high-risk non-muscle-invasive bladder cancer in African American patients
|
You, Sungyong
|
|
|
40 |
9 |
p. 410.e19-410.e27
|
artikel
|
| 5 |
Clinical utility of MR/ultrasound fusion-guided biopsy in patients with lower suspicion lesions on active surveillance for low-risk prostate cancer
|
Lokeshwar, Soum D.
|
|
|
40 |
9 |
p. 407.e21-407.e27
|
artikel
|
| 6 |
Clinical validation of IsoPSA, a single parameter, structure-focused assay for improved detection of prostate cancer: A prospective, multicenter study
|
Klein, Eric A.
|
|
|
40 |
9 |
p. 408.e9-408.e18
|
artikel
|
| 7 |
Cover 2 - Masthead
|
|
|
|
40 |
9 |
p. IFC
|
artikel
|
| 8 |
Effectiveness of adjuvant radiotherapy for high recurrence risk patients with upper tract urothelial carcinoma
|
Li, Xiaoying
|
|
|
40 |
9 |
p. 410.e1-410.e10
|
artikel
|
| 9 |
Free-hand, transrectal ultrasound-guided hydrodissection of the retroprostatic space during robot-assisted radical prostatectomy: Impact on the learning curve
|
Asimakopoulos, Anastasios D.
|
|
|
40 |
9 |
p. 408.e1-408.e8
|
artikel
|
| 10 |
Immune checkpoints inhibitors in the management of high-risk non-muscle-invasive bladder cancer. A scoping review
|
García-Perdomo, Herney Andrés
|
|
|
40 |
9 |
p. 409.e1-409.e8
|
artikel
|
| 11 |
Impact of an inpatient advanced practice provider on hospital length of stay after major urologic oncology procedures
|
Hull, Benjamin P.
|
|
|
40 |
9 |
p. 411.e19-411.e25
|
artikel
|
| 12 |
Impact of the primary tumor location on secondary sites and overall mortality in patients with metastatic upper tract urothelial carcinoma
|
Collà Ruvolo, Claudia
|
|
|
40 |
9 |
p. 411.e1-411.e8
|
artikel
|
| 13 |
Management of male sexual dysfunction after cancer treatment
|
Kim, Phillip
|
|
|
40 |
9 |
p. 389-394
|
artikel
|
| 14 |
Patient engagement in a mobile health intervention to improve preparedness for prostate biopsy
|
Balakrishnan, Ashwin S.
|
|
|
40 |
9 |
p. 407.e1-407.e7
|
artikel
|
| 15 |
Patient reported outcomes in advanced penile cancer
|
Youssef, Irini
|
|
|
40 |
9 |
p. 412.e9-412.e13
|
artikel
|
| 16 |
Serum IL-6 level is associated with clinical outcome of intravesical gemcitabine therapy in T1 non-muscle–invasive bladder cancer
|
Tong, Shiyu
|
|
|
40 |
9 |
p. 412.e1-412.e8
|
artikel
|
| 17 |
Significance of metabolic tumor volume and total lesion uptake measured using Ga-68 labelled prostate-specific membrane antigen PET/CT in primary staging of prostate cancer
|
Kubilay, Eralp
|
|
|
40 |
9 |
p. 408.e19-408.e25
|
artikel
|
| 18 |
The clinical value of circulating free tumor DNA in testicular germ cell tumor patients
|
Boublikova, Ludmila
|
|
|
40 |
9 |
p. 412.e15-412.e24
|
artikel
|
| 19 |
TIM-3 and TIGIT are possible immune checkpoint targets in patients with bladder cancer
|
Attalla, Kyrollis
|
|
|
40 |
9 |
p. 403-406
|
artikel
|
| 20 |
Tolerability and treatment outcome of pembrolizumab in patients with advanced urothelial carcinoma and severe renal dysfunction
|
Kita, Yuki
|
|
|
40 |
9 |
p. 410.e11-410.e18
|
artikel
|
| 21 |
Treatment patterns and rates of upgrading and upstaging in prostate cancer patients with single GGG1 positive biopsy core
|
Hoeh, Benedikt
|
|
|
40 |
9 |
p. 407.e9-407.e19
|
artikel
|
| 22 |
Treatment with opioids in patients with locally advanced or metastatic urothelial carcinoma and matched non-cancer controls
|
Galsky, Matthew D.
|
|
|
40 |
9 |
p. 411.e9-411.e18
|
artikel
|
Tijdschrift beschrijving